SecBot SecBot

MDCXW

Medicus Pharma Ltd.
Nasdaq· Pharmaceutical Preparations· Inc. A6· CIK 0001997296 Biotech & Drug Discovery
Warrants of Medicus Pharma Ltd. · MDCX stock page →
—
Market cap
$397.3K
Nano cap
1 year
−97.9%
from $119.50 · Oct 27
30 days
−67.0%
from $7.60
52-week range
$2.50–123.50
−98% from high · low Oct 23
Avg volume 20D
88.2K
Oct 9 spike 346.6K
Short interest
25.2K
≈0.0% of shares · −8.9%
Days to cover
67.8
at average volume
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
4
analyzed by SecBot
SecBot read BEARISH 4 reports · latest
Balance 3 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 4/4
Strongest BEARISH Medicus Pharma entered into a $22M secured note financing with Streeterville Capital, with $12M received…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 1 added (0 new), 0 trimmed or exited.

  • Short sellersSTEADY

    Short interest −8.9% to 25.2K shares. 67.8 days to cover, ≈0.0% of shares.

  • TrendDOWNTREND

    69% below its 50-day average. New closing low $2.50 on Oct 23.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGADD2,203$1.4K
Private Advisor Group, LLCDOUBLED39,000$34.5K

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 12, 2026
Trading halt
Halt Resumed: MDCXW — trading resumed after T3 (News and Resumption Times)
Halted 2026-10-09T23:50:00.000Z | Resumed 2026-10-12T13:05:00.000Z
Oct 9, 2026
Trading halt
Trading Halt: MDCXW — T3 (News and Resumption Times)
Medicus Pharma Ltd. Wt | Market: NASDAQ | Code: T3 — News and Resumption Times

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Sep 30, 2026
25,210
shares short
-8.9%
vs prior settlement
67.8
days to cover
≈0.0%
of shares outstanding
Trading halts
Oct 9, 2026Resumption ScheduledResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 12, 2026 Trading halt
Halt Resumed: MDCXW — trading resumed after T3 (News and Resumption Times)
Halted 2026-10-09T23:50:00.000Z | Resumed 2026-10-12T13:05:00.000Z
Jun 30, 2026 Inst.
UBS Group AG — ADD
2,203 shares ($1.4K)
May 27, 2026 SEC
Medicus Pharma entered into a $22M secured note financing with Streeterville Capital, with $12M received upfront and…
8-K — Impact 8/10
Apr 29, 2026 SEC
Medicus Pharma Ltd. filed Amendment No. 1 to its 2025 Form 10-K solely to add Part III information (directors…
10-K/A — Impact 2/10
Apr 24, 2026 SEC
Medicus Pharma received a Nasdaq delisting notice for failing to maintain a $1.00 minimum bid price and simultaneously…
8-K — Impact 8/10
Jun 30, 2025 Inst.
Private Advisor Group, LLC — DOUBLED
39,000 shares ($34.5K)

SecBot reports

4 filings · 0 bullish · 3 bearish · 1 neutral
All MDCXW filing & press-release reports (4)